医学
前列腺癌
正电子发射断层摄影术
磁共振成像
背景(考古学)
放射科
谷氨酸羧肽酶Ⅱ
荟萃分析
系统回顾
前列腺
科克伦图书馆
核医学
医学物理学
前列腺特异性抗原
癌症
梅德林
病理
内科学
法学
古生物学
生物
政治学
作者
Celeste Manfredi,Esaú Fernández‐Pascual,Davide Arcaniolo,Mark Emberton,Rafael Sánchez-Salas,Carlos Artigas,Fernando J. Bianco,Paul J. Cathcart,Declan G. Murphy,Felipe Couñago,Claudio Martínez‐Ballesteros,Paolo Verze,Juan Ignacio Martínez‐Salamanca
标识
DOI:10.1016/j.euf.2021.08.013
摘要
Prostate-specific membrane antigen (PSMA) positron emission tomography/magnetic resonance imaging (PET/MRI) is a novel imaging technique with several potential applications in the prostate cancer (PCa) setting.To perform a systematic review of the current evidence regarding the diagnostic performance of PSMA PET/MRI in patients with primary and recurrent PCa.A comprehensive bibliographic search on the MEDLINE and Cochrane Library databases was performed in October 2020. The review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement. Studies were deemed eligible if they assessed patients with primary or recurrent PCa (P) undergoing PSMA PET/MRI (I) with or without comparison with other imaging techniques (C) in order to evaluate its diagnostic performance (O). Retrospective and prospective primary clinical studies were included. Results of previous meta-analyses were reported.A total of 23 original articles and three meta-analyses were included. Limited evidence on PSMA PET/MRI is available, especially in the setting of partial gland ablation. PET/MRI can be an effective imaging modality for detecting primary PCa, showing higher accuracy than multiparametric MRI alone. It provides accurate local staging of primary PCa; however, there are contradictory results in this context when its performance is compared with other imaging techniques. PET/MRI also shows high performance for restaging and detecting tumor recurrence, even at low prostate-specific antigen levels.PSMA PET/MRI could represent a valuable tool in the management of patients with primary and recurrent PCa. No specific recommendations can be provided.Encouraging data regarding the benefits of prostate-specific membrane antigen positron emission tomography/magnetic resonance imaging in patients with prostate cancer are emerging from the literature.
科研通智能强力驱动
Strongly Powered by AbleSci AI